QUOTE AND NEWS
StreetInsider.com  Nov 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vanda+Pharma+%28VNDA%29+Tops+by+3c%2C+Posts+Q3+Loss+of+%240.28/5062754.html for the full story.
PR Newswire  Oct 28  Comment 
ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system
Stock Blog Hub  Oct 20  Comment 
Avnet, Inc. (AVT) recently announced that it has acquired a controlling interest in Vanda Group from Hutchinson Whampoa Limited in a strategic move to expand its presence and customer base across China. Vanda Group will operate as an Avnet company...
FiercePharma  Oct 13  Comment 
Today's big Novartis news: The Swiss drugmaker has scooped up U.S. and Canadian rights to Vanda Pharmaceuticals' new schizophrenia remedy Fanapt for up to $465 million in up-front and milestone payments, plus royalties. It gets the right to...
TheStreet.com  Oct 13  Comment 
Bulls were hoping for a Vanda takeover.
TheStreet.com  Sep 15  Comment 
Vanda's chances of getting acquired seem to be drying up, according to two analysts.
Stock Gumshoe  Aug 19  Comment 
Today's tasty delight from the annals of teaserdom is a little bit different from what I usually cover -- this time it's a teaser for a trading service that's about to launch. It's a new service from Mike Turner at StreetAuthority that they're...
Jutia Group  Aug 11  Comment 
So your stock just went way up, now what do you do? We often hear from concerned investors who aren’t sure whether to hold on or sell it all after a huge gain. For example, I’m used to explosive gains in the biotech world, but I’ve never...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):
 
VNDA AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki